| 17beta-estradiol | increases expression | ISO | RGD:1343149 | 6480464 | Estradiol results in increased expression of HLA-C mRNA | CTD | PMID:19619570 |
| 17beta-estradiol | multiple interactions | ISO | RGD:1352836 | 6480464 | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of HLA-B mRNA | CTD | PMID:19619570 |
| 17beta-estradiol | increases expression | ISO | RGD:1352836 | 6480464 | Estradiol results in increased expression of HLA-B mRNA | CTD | PMID:19619570 |
| 17beta-estradiol | affects expression | ISO | RGD:1619267 | 6480464 | Estradiol affects the expression of H2-D1 mRNA | CTD | PMID:15598610 |
| 17beta-estradiol | multiple interactions | ISO | RGD:1343149 | 6480464 | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of HLA-C mRNA | CTD | PMID:19619570 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1343149 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of HLA-C mRNA | CTD | PMID:19619570 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1352836 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of HLA-B mRNA | CTD | PMID:20106945 PMID:21632981 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1352836 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of HLA-B mRNA | CTD | PMID:19619570 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1352836 | 6480464 | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of HLA-B mRNA | CTD | PMID:19619570 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1619267 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of H2-D1 mRNA | CTD | PMID:16891777 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1619267 | 6480464 | AHR protein affects the reaction [Tetrachlorodibenzodioxin results in increased expression of H2-D1 mRNA] | CTD | PMID:16891777 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1343149 | 6480464 | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of HLA-C mRNA | CTD | PMID:19619570 |
| 4-(ethoxymethylene)-2-phenyloxazol-5-one | increases expression | ISO | RGD:1352836 | 6480464 | Oxazolone results in increased expression of HLA-B mRNA | CTD | PMID:17374397 |
| aflatoxin B1 | decreases expression | ISO | RGD:1619267 | 6480464 | Aflatoxin B1 results in decreased expression of H2-D1 mRNA | CTD | PMID:19770486 |
| all-trans-retinoic acid | increases expression | ISO | RGD:1343149 | 6480464 | Tretinoin results in increased expression of HLA-C mRNA | CTD | PMID:17218384 PMID:15498508 |
| all-trans-retinoic acid | increases expression | ISO | RGD:1352836 | 6480464 | Tretinoin results in increased expression of HLA-B mRNA | CTD | PMID:15894607 PMID:17218384 |
| all-trans-retinoic acid | increases expression | ISO | RGD:1343149 | 6480464 | Tretinoin results in increased expression of HLA-C mRNA | CTD | PMID:15498508 PMID:17218384 |
| allopurinol | increases response to substance | ISO | RGD:1352836 | 6480464 | HLA-B gene polymorphism results in increased susceptibility to Allopurinol | CTD | PMID:15743917 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of RT1-CE7 mRNA | CTD | PMID:16483693 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:1619267 | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in increased expression of H2-D1 mRNA | CTD | PMID:21715664 |
| benzo[a]pyrene | affects expression | ISO | RGD:1619267 | 6480464 | Benzo(a)pyrene affects the expression of HLA-C mRNA; more ... | CTD | PMID:22342234 |
| benzo[a]pyrene | increases expression | ISO | RGD:1619267 | 6480464 | Benzo(a)pyrene results in increased expression of H2-D1 mRNA | CTD | PMID:21715664 |
| beryllium sulfate | increases expression | ISO | RGD:1343149 | 6480464 | beryllium sulfate results in increased expression of HLA-C mRNA | CTD | PMID:16314022 |
| bis(2-ethylhexyl) phthalate | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of RT1-CE7 promoter | CTD | PMID:23359474 |
| bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of RT1-CE7 promoter | CTD | PMID:23359474 |
| cadmium dichloride | decreases methylation | EXP | | 6480464 | Cadmium Chloride results in decreased methylation of RT1-CE7 promoter | CTD | PMID:22457795 |
| carbamazepine | affects response to substance | ISO | RGD:1352836 | 6480464 | HLA-B gene SNP affects the susceptibility to Carbamazepine | CTD | PMID:16538176 |
| carbamazepine | affects response to substance | ISO | RGD:1352836 | 6480464 | HLA-B gene polymorphism affects the susceptibility to Carbamazepine | CTD | PMID:18855540 more ... |
| cisplatin | multiple interactions | ISO | RGD:1343149 | 6480464 | [Piroxicam co-treated with Cisplatin] results in increased expression of HLA-C mRNA | CTD | PMID:21858171 |
| cobalt dichloride | increases expression | ISO | RGD:1343149 | 6480464 | cobaltous chloride results in increased expression of HLA-C mRNA | CTD | PMID:19320972 PMID:19376846 |
| cobalt dichloride | increases expression | ISO | RGD:1352836 | 6480464 | cobaltous chloride results in increased expression of HLA-B mRNA | CTD | PMID:19320972 PMID:19376846 |
| copper(II) chloride | increases expression | ISO | RGD:1619267 | 6480464 | cupric chloride results in increased expression of H2-D1 mRNA | CTD | PMID:17211630 |
| cyclosporin A | increases expression | ISO | RGD:1343149 | 6480464 | Cyclosporine results in increased expression of HLA-C mRNA | CTD | PMID:22147139 |
| D-penicillamine | affects response to substance | ISO | RGD:1352836 | 6480464 | HLA-B gene polymorphism affects the susceptibility to Penicillamine | CTD | PMID:3437418 more ... |
| diarsenic trioxide | decreases expression | ISO | RGD:1343149 | 6480464 | arsenic trioxide results in decreased expression of HLA-C mRNA | CTD | PMID:15761015 PMID:15725085 |
| diarsenic trioxide | decreases expression | ISO | RGD:1352836 | 6480464 | arsenic trioxide results in decreased expression of HLA-B mRNA | CTD | PMID:15725085 more ... |
| diarsenic trioxide | decreases expression | ISO | RGD:1343149 | 6480464 | arsenic trioxide results in decreased expression of HLA-C mRNA | CTD | PMID:15725085 PMID:15761015 |
| diarsenic trioxide | increases expression | ISO | RGD:1343149 | 6480464 | arsenic trioxide results in increased expression of HLA-C mRNA | CTD | PMID:20458559 |
| dibutyl phthalate | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of RT1-CE7 promoter | CTD | PMID:23359474 |
| diethylstilbestrol | decreases expression | ISO | RGD:1619267 | 6480464 | Diethylstilbestrol results in decreased expression of H2-D1 mRNA | CTD | PMID:15171707 |
| elemental selenium | increases expression | ISO | RGD:1343149 | 6480464 | Selenium results in increased expression of HLA-C mRNA | CTD | PMID:19244175 |
| elemental selenium | increases expression | ISO | RGD:1352836 | 6480464 | Selenium results in increased expression of HLA-B mRNA | CTD | PMID:19244175 |
| eugenol | increases expression | ISO | RGD:1352836 | 6480464 | Eugenol results in increased expression of HLA-B mRNA | CTD | PMID:17374397 |
| flucloxacillin | affects response to substance | ISO | RGD:1352836 | 6480464 | HLA-B gene polymorphism affects the susceptibility to Floxacillin | CTD | PMID:19483685 |
| fumonisin B1 | increases expression | ISO | RGD:1619267 | 6480464 | fumonisin B1 results in increased expression of H2-D1 mRNA | CTD | PMID:16221962 |
| gold atom | affects response to substance | ISO | RGD:1352836 | 6480464 | HLA-B gene polymorphism affects the susceptibility to Gold | CTD | PMID:3084782 |
| gold(0) | affects response to substance | ISO | RGD:1352836 | 6480464 | HLA-B gene polymorphism affects the susceptibility to Gold | CTD | PMID:3084782 |
| hydralazine | multiple interactions | ISO | RGD:1352836 | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of HLA-B mRNA | CTD | PMID:17183730 |
| hydrogen peroxide | decreases expression | ISO | RGD:1343149 | 6480464 | Hydrogen Peroxide results in decreased expression of HLA-C mRNA | CTD | PMID:12419474 |
| lamotrigine | affects response to substance | ISO | RGD:1352836 | 6480464 | HLA-B gene polymorphism affects the susceptibility to lamotrigine | CTD | PMID:20235791 PMID:20485159 |
| menadione | affects expression | ISO | RGD:1343149 | 6480464 | Vitamin K 3 affects the expression of HLA-C mRNA | CTD | PMID:20044591 |
| menadione | affects expression | ISO | RGD:1619267 | 6480464 | Vitamin K 3 affects the expression of HLA-C mRNA | CTD | PMID:20829426 |
| mitomycin C | decreases expression | ISO | RGD:1343149 | 6480464 | Mitomycin results in decreased expression of HLA-C mRNA | CTD | PMID:12760830 |
| N-nitrosodiethylamine | decreases expression | ISO | RGD:1619267 | 6480464 | Diethylnitrosamine results in decreased expression of H2-D1 mRNA | CTD | PMID:17942915 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:1619267 | 6480464 | MET protein inhibits the reaction [Diethylnitrosamine results in decreased expression of H2-D1 mRNA] | CTD | PMID:17942915 |
| nickel sulfate | increases expression | ISO | RGD:1352836 | 6480464 | nickel sulfate results in increased expression of HLA-B mRNA | CTD | PMID:17374397 |
| oxcarbazepine | affects response to substance | ISO | RGD:1352836 | 6480464 | HLA-B gene polymorphism affects the susceptibility to oxcarbazepine | CTD | PMID:20235791 |
| phenytoin | affects response to substance | ISO | RGD:1352836 | 6480464 | HLA-B gene polymorphism affects the susceptibility to Phenytoin | CTD | PMID:20235791 |
| pirinixic acid | decreases expression | ISO | RGD:1619267 | 6480464 | pirinixic acid results in decreased expression of H2-D1 mRNA | CTD | PMID:20813756 PMID:16221962 |
| pirinixic acid | decreases expression | ISO | RGD:1619267 | 6480464 | pirinixic acid results in decreased expression of H2-D1 mRNA | CTD | PMID:16221962 PMID:20813756 |
| piroxicam | multiple interactions | ISO | RGD:1343149 | 6480464 | [Piroxicam co-treated with Cisplatin] results in increased expression of HLA-C mRNA | CTD | PMID:21858171 |
| propiconazole | decreases expression | ISO | RGD:1619267 | 6480464 | propiconazole results in decreased expression of H2-D1 mRNA | CTD | PMID:21278054 |
| selenium atom | increases expression | ISO | RGD:1343149 | 6480464 | Selenium results in increased expression of HLA-C mRNA | CTD | PMID:19244175 |
| selenium atom | increases expression | ISO | RGD:1352836 | 6480464 | Selenium results in increased expression of HLA-B mRNA | CTD | PMID:19244175 |
| tamibarotene | increases expression | ISO | RGD:1343149 | 6480464 | Am 80 results in increased expression of HLA-C mRNA; more ... | CTD | PMID:15498508 |
| tert-butyl hydroperoxide | decreases expression | ISO | RGD:1343149 | 6480464 | tert-Butylhydroperoxide results in decreased expression of HLA-C mRNA | CTD | PMID:12419474 PMID:15336504 |
| tert-butyl hydroperoxide | decreases expression | ISO | RGD:1352836 | 6480464 | tert-Butylhydroperoxide results in decreased expression of HLA-B mRNA | CTD | PMID:15336504 |
| tetrachloromethane | affects expression | ISO | RGD:1619267 | 6480464 | Carbon Tetrachloride affects the expression of H2-D1 mRNA | CTD | PMID:17484886 |
| valproic acid | increases expression | ISO | RGD:1343149 | 6480464 | Valproic Acid results in increased expression of HLA-C mRNA | CTD | PMID:19101580 |
| valproic acid | increases expression | ISO | RGD:1352836 | 6480464 | Valproic Acid results in increased expression of HLA-B mRNA | CTD | PMID:19101580 |
| valproic acid | multiple interactions | ISO | RGD:1352836 | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of HLA-B mRNA | CTD | PMID:17183730 |
| vancomycin | decreases expression | ISO | RGD:1619267 | 6480464 | Vancomycin results in decreased expression of H2-D1 mRNA | CTD | PMID:18930951 |